FDA official logo
GSRS logo
PFDA official logo

CANTUZUMAB RAVTANSINE

  • UNII: RNQ8JQ4R9P
  • Preferred Substance Name: CANTUZUMAB RAVTANSINE

  • 868747-45-9
  • CANTUZUMAB RAVTANSINE [INN]
  • CANTUZUMAB RAVTANSINE [USAN]
  • CANTUZUMAB RAVTANSINE [WHO-DD]
  • HUC242-DM4
  • IMGN242
  • IMGN-242
  • IMMUNOGLOBULIN G1, ANTI-(MUCIN CANAG) (HUMAN-MOUSE MONOCLONAL C242 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL C242 LIGHT CHAIN, DIMER, TETRAAMIDE WITH N2'-(4-((3-CARBOXYPROPYL)DITHIO)-4-METHYL-1-OXOPENTYL)-N2'-DEACETYLMAYTANSINE

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.




About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

Powered by

DNAnexus official logo